TAMR Recognized at International Stem Cell Summit
| FOR IMMEDIATE RELEASE June 15, 2005 |
CONTACT: Judy Haley (713) 464-8707 Joe Brown (713) 218-8888 |
Texans for the Advancement of Medical Research (TAMR) was honored at an international stem cell research conference in Houston recently for its grassroots effort in bipartisan coalition building to protect stem cell research in Texas.
TAMR received the Grassroots Advocacy Award from the Genetics Policy Institute (GPI) which sponsored the conference, Stem Cell Policy and Advocacy Summit: Sustaining the Mandate for Cures, at Baylor College of Medicine.
We are honored and humbled to receive this award from the Genetics Policy Institute, said TAMR President Judy Haley. In only two and a half years, TAMR has grown from a handful of individuals with poignant stories into a purpose-driven organization of scientists, physicians, ethicists, and advocates who believe that regenerative therapy will be the bedrock of 21st century medicine, and must be protected in Texas.
GPI, a Florida-based, nonprofit organization, focuses on the establishment of a legal framework to advance the search for cutting-edge cures, specifically emphasizing stem cell research. Using a variety of venues GPI educates the public about the importance of banning unethical reproductive cloning while keeping life-saving research legal throughout the world.
TAMR is a model of the passion and persistence that advocates must harness to be winners, Bernard Siegel, founder and executive director of GPI, said. This group received GPIs first Grassroots Advocacy Award because it came together in a time of crisis, developed a clear and honest message, identified champions in the Legislature and partners in the science community, and then fought incredible odds to successfully protect stem cell research in the State of Texas.
Stem cell research has the potential to cure a wide array of diseases, including diabetes, Parkinsons, muscular dystrophy, multiple sclerosis, spinal cord injury, heart disease, and many others. In addition to creating replacement cells for those damaged or destroyed by disease, embryonic stem cells hold the key to understanding the development of disease from its earliest stages, and to creating treatment interventions including drug therapy and gene therapy.
TAMR is composed of leading scientists, physicians, ethicists, health groups, and individuals who support biomedical research for the purpose of curing diseases and alleviating suffering. TAMR was created during the 78th legislative session, in 2003,in response to the threat to stem cell research in Texas. TAMR is helping to build a bi-partisan coalition within the Texas legislature that supports all types of stem cell research for regenerative medicine.
Filed under: TAMR


